BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Porela-Tiihonen S, Kokki M, Kokki H. Sufentanil sublingual formulation for the treatment of acute, moderate to severe postoperative pain in adult patients. Expert Rev Neurother 2017;17:101-11. [PMID: 27835931 DOI: 10.1080/14737175.2017.1260005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Gupta AK, Mena S, Jin Z, Gan TJ, Bergese S. Postoperative pain: a review of emerging therapeutic options. Expert Rev Neurother 2021;21:1085-100. [PMID: 34461794 DOI: 10.1080/14737175.2021.1974840] [Reference Citation Analysis]
2 Piccioni F, Segat M, Falini S, Umari M, Putina O, Cavaliere L, Ragazzi R, Massullo D, Taurchini M, Del Naja C, Droghetti A. Enhanced recovery pathways in thoracic surgery from Italian VATS Group: perioperative analgesia protocols. J Thorac Dis 2018;10:S555-63. [PMID: 29629202 DOI: 10.21037/jtd.2017.12.86] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
3 Deeks ED. Sufentanil 30 µg Sublingual Tablet: A Review in Acute Pain. Clin Drug Investig 2019;39:411-8. [PMID: 30887417 DOI: 10.1007/s40261-019-00772-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Piirainen A, Kokki M, Lidsle HM, Lehtonen M, Ranta VP, Kokki H. Absorption of ibuprofen orodispersible tablets in early postoperative phase - a pharmacokinetic study. Curr Med Res Opin 2018;34:683-8. [PMID: 29043849 DOI: 10.1080/03007995.2017.1394832] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Zhao L, Li Y. Application of dexmedetomidine combined with sufentanil in colon cancer resection and its effect on immune and coagulation function of patients. Oncol Lett 2020;20:1288-94. [PMID: 32724370 DOI: 10.3892/ol.2020.11643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Valtola A, Morse JD, Florkiewicz P, Hautajärvi H, Lahtinen P, Musialowicz T, Anderson BJ, Ranta VP, Kokki H. Bioavailability of oxycodone by mouth in coronary artery bypass surgery patients - a randomized trial. J Drug Assess 2020;9:117-28. [PMID: 32939317 DOI: 10.1080/21556660.2020.1797753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Porela-tiihonen S, Kokki H, Kokki M. An up-to-date overview of sublingual sufentanil for the treatment of moderate to severe pain. Expert Opinion on Pharmacotherapy 2020;21:1407-18. [DOI: 10.1080/14656566.2020.1766025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Valtola A, Laakso M, Hakomäki H, Anderson BJ, Kokki H, Ranta VP, Rinne V, Kokki M. Intranasal Fentanyl for Intervention-Associated Breakthrough Pain After Cardiac Surgery. Clin Pharmacokinet 2021;60:907-19. [PMID: 33686630 DOI: 10.1007/s40262-021-01002-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pogatzki-zahn E, Kranke P, Winner J, Weyland W, Reich A, Vigelius-rauch U, Paland M, Löhr T, Eberhart L. Real-world use of the sufentanil sublingual tablet system for patient-controlled management of acute postoperative pain: a prospective noninterventional study. Current Medical Research and Opinion 2020;36:277-84. [DOI: 10.1080/03007995.2019.1681133] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]